Natalja J.
- Country
- Sweden
- Department
- Pediatric Oncology and Stem Cell Transplantation
Research Overview
- Phase III Randomized Trial Comparing Clofarabine, Fludarabine, and Busulfan vs. Busulfan, Cyclophosphamide, and Melphalan in Pediatric Acute Myeloid Leukemia Transplant Conditioning
- Evaluation of Non-Total Body Irradiation Conditioning Regimens with Fludarabine, Thiotepa, and Busulfan in Pediatric Acute Lymphoblastic Leukemia Transplantation
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL.
Data & Insights
Has run more than one trial at 47 of 87 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating acute leukemia conditions, with particular focus on both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in pediatric populations.
- Pediatric Leukemia Treatment
- Blood Cancer Therapeutics
- Hematologic Malignancies
Their work encompasses innovative approaches to blood cancer treatment in young patients.
Transplantation Medicine
The investigator focuses on stem cell transplantation procedures, particularly in the context of treating pediatric and adolescent patients with blood disorders.
- Allogeneic Transplantation
- Conditioning Regimens
- Donor Matching Protocols
Their expertise extends to various transplantation approaches including matched sibling donor and alternative donor sources.
Pediatric Medicine
The investigator specializes in pediatric oncology with particular emphasis on developing treatment protocols for children and adolescents with blood cancers.
- Child and Adolescent Cancer Care
- Age-Specific Treatment Protocols
- Pediatric Cancer Therapeutics
Their work focuses on optimizing treatment outcomes for young patients requiring intensive therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.